US · 21 CFR
21 CFR Part 610
General Biological Products Standards
eCFR, up to date as of 2026-11-12
Table of contents
- 610.1Tests prior to release required for each lot.
- 610.2Requests for samples and protocols; official release.
- 610.9Equivalent methods and processes.
- 610.10Potency.
- 610.12Sterility.
- 610.13Purity.
- 610.14Identity.
- 610.15Constituent materials.
- 610.16Total solids in serums.
- 610.17Permissible combinations.
- 610.18Cultures.
- 610.39Definitions.
- 610.40Test requirements.
- 610.41Donor deferral.
- 610.42Restrictions on use for further manufacture of medical devices.
- 610.44Use of reference panels by manufacturers of test kits.
- 610.46Human immunodeficiency virus (HIV) “lookback” requirements.
- 610.47Hepatitis C virus (HCV) “lookback” requirements.
- 610.50Date of manufacture for biological products.
- 610.53Dating periods for Whole Blood and blood components.
- 610.60Container label.
- 610.61Package label.
- 610.62Proper name; package label; legible type.
- 610.63Divided manufacturing responsibility to be shown.
- 610.64Name and address of distributor.
- 610.65Products for export.
- 610.67Bar code label requirements.
- 610.68Exceptions or alternatives to labeling requirements for biological products held by the Strategic National Stockpile.
Cover page and contents (original)
Authority:21 U.S.C. 321, 331, 351, 352, 353, 355, 360, 360c, 360d, 360h, 360i, 371, 372, 374, 381; 42 U.S.C. 216, 262, 263, 263a, 264.
Source:38 FR 32056, Nov. 20, 1973, unless otherwise noted.
Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-16